Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible
Overview
Authors
Affiliations
Background: A right- or left-sided liver resection can be considered in about half of patients with perihilar cholangiocarcinoma (pCCA), depending on tumor location and vascular involvement. This study compared postoperative mortality and long-term survival of right- versus left-sided liver resections for pCCA.
Methods: Patients who underwent major liver resection for pCCA at 25 Western centers were stratified according to the type of hepatectomy-left, extended left, right, and extended right. The primary outcomes were 90-day mortality and overall survival (OS).
Results: Between 2000 and 2022, 1701 patients underwent major liver resection for pCCA. The 90-day mortality was 9% after left-sided and 18% after right-sided liver resection (p < 0.001). The 90-day mortality rates were 8% (44/540) after left, 11% (29/276) after extended left, 17% (51/309) after right, and 19% (108/576) after extended right hepatectomy (p < 0.001). Median OS was 30 months (95% confidence interval [CI] 27-34) after left and 23 months (95% CI 20-25) after right liver resection (p < 0.001), and 33 months (95% CI 28-38), 27 months (95% CI 23-32), 25 months (95% CI 21-30), and 21 months (95% CI 18-24) after left, extended left, right, and extended right hepatectomy, respectively (p < 0.001). A left-sided resection was an independent favorable prognostic factor for both 90-day mortality and OS compared with right-sided resection, with similar results after excluding 90-day fatalities.
Conclusions: A left or extended left hepatectomy is associated with a lower 90-day mortality and superior OS compared with an (extended) right hepatectomy for pCCA. When both a left and right liver resection are feasible, a left-sided liver resection is preferred.
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience.
Jain A, Lendoire M, Haddad A, Tzeng C, Boyev A, Maki H Ann Surg Oncol. 2025; .
PMID: 40000564 DOI: 10.1245/s10434-025-17075-5.
Al-Saffar H, Larsen P, Schultz N, Kristensen T, Renteria D, Knofler L Langenbecks Arch Surg. 2024; 410(1):13.
PMID: 39708095 DOI: 10.1007/s00423-024-03583-7.
Major Hepatectomy for Perihilar Cholangiocarcinoma: Taking Sides.
Soreide K Ann Surg Oncol. 2024; 31(7):4169-4172.
PMID: 38517613 DOI: 10.1245/s10434-024-15211-1.